ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 69852 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 69852; 2) Community: the network communities that were significantly associated with the response to NSC 69852; 3) Molecule: the relationships between components within communities and NSC 69852; 4) MDR: the compounds that were significantly associated with the NSC 69852.

NSC Compound Enrichment Correlation
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.038506707102734 0.21537966
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.038506707102734 0.52140962
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 0.038506707102734 0.42109382
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.038506707102734 0.53229451
NSC 743862 Null 0.038506707102734 0.36450743
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.038506707102734 0.19231139
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0385067071027343 0.071325026
NSC 1393 4-APP 0.0385067071027343 0.31268548
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0385067071027343 0.035407906
NSC 176503 Fastigilin B 0.0385067071027343 0.60404425
Total:122  Current:100    [First] [Prev] [Next] [Last]